Comparison the prevalence of isolated Hepatitis B core antibody among injection drug users with blood donors in central province in IRAN

Background: In healthy blood donors, 2%–5% have isolated anti-HBc. Prevalence of hepatitis B, C and co- infection (HBV +HCV) among injection drug user is high. Hepatitis C suppress of HB SAg and may be hepatitis B presented only with isolated anti HBC. This study determined of prevalence o...

Full description

Bibliographic Details
Main Authors: Masoomeh Soufian, Fatemeh Sadat Mahdaviani, Nabiollah Izadi, Ali Mousavinejad, Hossein Sarmadian, Nader Zarrinfar, Manizheh Kahbazi, Ali Asghar Farazi
Format: Article
Language:English
Published: Bushehr University of Medical Sciences 2011-09-01
Series:Iranian South Medical Journal
Subjects:
Online Access:http://ismj.bpums.ac.ir/browse.php?a_code=A-10-3-232&slc_lang=en&sid=1
_version_ 1818142619221360640
author Masoomeh Soufian
Fatemeh Sadat Mahdaviani
Nabiollah Izadi
Ali Mousavinejad
Hossein Sarmadian
Nader Zarrinfar
Manizheh Kahbazi
Ali Asghar Farazi
author_facet Masoomeh Soufian
Fatemeh Sadat Mahdaviani
Nabiollah Izadi
Ali Mousavinejad
Hossein Sarmadian
Nader Zarrinfar
Manizheh Kahbazi
Ali Asghar Farazi
author_sort Masoomeh Soufian
collection DOAJ
description Background: In healthy blood donors, 2%–5% have isolated anti-HBc. Prevalence of hepatitis B, C and co- infection (HBV +HCV) among injection drug user is high. Hepatitis C suppress of HB SAg and may be hepatitis B presented only with isolated anti HBC. This study determined of prevalence of isolated anti HBC among injection drug users and compare with blood donors in Arak city. Methods: A total 684 subjects (531voluntary blood donors and 153 injection drug users) in Arak, Iran were included in this study. Hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), anti-HBc, and hepatitis C antibody (anti-HCV) were tested in all subjects. Results: A total of 531 voluntary blood donors living in the city of Arak, in the Central Province of Iran, with a mean age of 36 ± 10.18 years (range 16–60 years) were enrolled in the study. Ninety-three percent of patients were male and 7% were female. Of the 531 cases, 11 subjects (2.1%) had isolated anti-HBc. A total of 153 injection drug users of Arak, in the Central Province of Iran, with a mean age of 30.66 ± 5.92 years (range 20-50 years) were enrolled in the study. All of them were male. Of the 153 cases, 12 subjects (7.84%) had isolated anti-HBc. All of 12 cases were HCV positive. Conclusion: Prevalence of isolated anti-HBc among injection drug users was 3. 73 fold in comparison with blood donors. For diagnosis of hepatitis B in this group test for anti-HBc will be done. Evaluation of occult hepatitis B in subject with isolated anti-HBc by exact method such as real time PCR is necessary.
first_indexed 2024-12-11T11:18:39Z
format Article
id doaj.art-645a540b8c8d4474b7fd9064a5a49c33
institution Directory Open Access Journal
issn 1735-4374
1735-6954
language English
last_indexed 2024-12-11T11:18:39Z
publishDate 2011-09-01
publisher Bushehr University of Medical Sciences
record_format Article
series Iranian South Medical Journal
spelling doaj.art-645a540b8c8d4474b7fd9064a5a49c332022-12-22T01:09:14ZengBushehr University of Medical SciencesIranian South Medical Journal1735-43741735-69542011-09-01143173178Comparison the prevalence of isolated Hepatitis B core antibody among injection drug users with blood donors in central province in IRANMasoomeh Soufian0Fatemeh Sadat Mahdaviani1Nabiollah Izadi2Ali Mousavinejad3Hossein Sarmadian4Nader Zarrinfar5Manizheh Kahbazi6Ali Asghar Farazi7 Background: In healthy blood donors, 2%–5% have isolated anti-HBc. Prevalence of hepatitis B, C and co- infection (HBV +HCV) among injection drug user is high. Hepatitis C suppress of HB SAg and may be hepatitis B presented only with isolated anti HBC. This study determined of prevalence of isolated anti HBC among injection drug users and compare with blood donors in Arak city. Methods: A total 684 subjects (531voluntary blood donors and 153 injection drug users) in Arak, Iran were included in this study. Hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), anti-HBc, and hepatitis C antibody (anti-HCV) were tested in all subjects. Results: A total of 531 voluntary blood donors living in the city of Arak, in the Central Province of Iran, with a mean age of 36 ± 10.18 years (range 16–60 years) were enrolled in the study. Ninety-three percent of patients were male and 7% were female. Of the 531 cases, 11 subjects (2.1%) had isolated anti-HBc. A total of 153 injection drug users of Arak, in the Central Province of Iran, with a mean age of 30.66 ± 5.92 years (range 20-50 years) were enrolled in the study. All of them were male. Of the 153 cases, 12 subjects (7.84%) had isolated anti-HBc. All of 12 cases were HCV positive. Conclusion: Prevalence of isolated anti-HBc among injection drug users was 3. 73 fold in comparison with blood donors. For diagnosis of hepatitis B in this group test for anti-HBc will be done. Evaluation of occult hepatitis B in subject with isolated anti-HBc by exact method such as real time PCR is necessary.http://ismj.bpums.ac.ir/browse.php?a_code=A-10-3-232&slc_lang=en&sid=1isolated anti-HBc injection drug users prevalence hepatitis
spellingShingle Masoomeh Soufian
Fatemeh Sadat Mahdaviani
Nabiollah Izadi
Ali Mousavinejad
Hossein Sarmadian
Nader Zarrinfar
Manizheh Kahbazi
Ali Asghar Farazi
Comparison the prevalence of isolated Hepatitis B core antibody among injection drug users with blood donors in central province in IRAN
Iranian South Medical Journal
isolated anti-HBc
injection drug users
prevalence
hepatitis
title Comparison the prevalence of isolated Hepatitis B core antibody among injection drug users with blood donors in central province in IRAN
title_full Comparison the prevalence of isolated Hepatitis B core antibody among injection drug users with blood donors in central province in IRAN
title_fullStr Comparison the prevalence of isolated Hepatitis B core antibody among injection drug users with blood donors in central province in IRAN
title_full_unstemmed Comparison the prevalence of isolated Hepatitis B core antibody among injection drug users with blood donors in central province in IRAN
title_short Comparison the prevalence of isolated Hepatitis B core antibody among injection drug users with blood donors in central province in IRAN
title_sort comparison the prevalence of isolated hepatitis b core antibody among injection drug users with blood donors in central province in iran
topic isolated anti-HBc
injection drug users
prevalence
hepatitis
url http://ismj.bpums.ac.ir/browse.php?a_code=A-10-3-232&slc_lang=en&sid=1
work_keys_str_mv AT masoomehsoufian comparisontheprevalenceofisolatedhepatitisbcoreantibodyamonginjectiondruguserswithblooddonorsincentralprovinceiniran
AT fatemehsadatmahdaviani comparisontheprevalenceofisolatedhepatitisbcoreantibodyamonginjectiondruguserswithblooddonorsincentralprovinceiniran
AT nabiollahizadi comparisontheprevalenceofisolatedhepatitisbcoreantibodyamonginjectiondruguserswithblooddonorsincentralprovinceiniran
AT alimousavinejad comparisontheprevalenceofisolatedhepatitisbcoreantibodyamonginjectiondruguserswithblooddonorsincentralprovinceiniran
AT hosseinsarmadian comparisontheprevalenceofisolatedhepatitisbcoreantibodyamonginjectiondruguserswithblooddonorsincentralprovinceiniran
AT naderzarrinfar comparisontheprevalenceofisolatedhepatitisbcoreantibodyamonginjectiondruguserswithblooddonorsincentralprovinceiniran
AT manizhehkahbazi comparisontheprevalenceofisolatedhepatitisbcoreantibodyamonginjectiondruguserswithblooddonorsincentralprovinceiniran
AT aliasgharfarazi comparisontheprevalenceofisolatedhepatitisbcoreantibodyamonginjectiondruguserswithblooddonorsincentralprovinceiniran